- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02595697
Communication Intervention for Toddlers With Autism (J-EMT)
An Efficacy Trail of Enhanced Milieu Teaching Language Intervention Plus Joint Attention, Engagement, Regulation Intervention for Toddlers With Autism
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study tests the blended intervention (J-EMT) in a parent-plus-therapist-implementation model that has been demonstrated to be effective with other populations.
The J-EMT communication intervention is tailored to the specific social communication characteristics of children with ASD and is delivered during a critical period in early communication development for these children.
In this study, the investigators compare this blended intervention (J-EMT) to a business as usual (BAU) comparison group. Children assigned to the J-EMT group will receive a total of 48, 1-hour direct intervention sessions over six months that will include teaching their parents to implement J-EMT procedures across daily activities.
The investigators will examine social communication and child vocalizations, expressive and receptive language, symbolic play, and symbol-infused joint engagement to determine whether J-EMT changes both a primary functional outcome and the underlying specific skills that contribute to effective social communication in children with ASD.
Results from this study will indicate the efficacy of this variation of parent-plus-therapist-implemented EMT (i.e., J-EMT) specifically tailored to the characteristics of young children with ASD.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Illinois
-
Evanston, Illinois, Forenede Stater, 60208
- Northwestern University
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37203
- Vanderbilt University
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Between 24 and 36 months of age
- A diagnosis of ASD as confirmed by the ADOS-2 (module 1)
- Signed informed consent
- Parent willing to be trained
Exclusion Criteria:
- Other diagnosis or disability
- Abnormal hearing and/or vision
- Language other than English is the primary language spoken at home
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Enkelt gruppeopgave
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Business as Usual kontrolgruppe
Alle børn, uanset gruppeopgave, deltager i alle vurderinger.
Børn randomiseret til kontrolgruppen vil ikke modtage intervention, men vil gennemføre alle andre forskningsprocedurer.
Andre behandlinger, som alle børn modtager i samfundet, vil blive registreret med halvmånedlige undersøgelser.
|
|
|
Eksperimentel: J-EMT for Toddlers with Autism
The J-EMT intervention:(a) teach foundational social communicative behaviors, (b) teach related skills that predict long term language outcomes, (c) teach a range of communicative functions, (d) target specific spoken language skills as well as foundational skills, (e) incorporate instructional methods, contexts, and partners that increase social use of language in natural contexts, and (f) promote generalization and maintenance of newly learned skills to everyday activities and routines.
In addition, because parents are essential partners for young children with ASD who are learning to communicate, studies are needed that (g) include parents and (h) specify the method and fidelity of parent instruction and fidelity and dosage with which parents use the trained strategies
|
Children assigned to the J-EMT group will receive a total of 48, 1-hour direct intervention sessions over six months that will include teaching their parents to implement J-EMT procedures across daily activities.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Number of spontaneous social communication attempts made as assessed by a 20 minute lanugage sample.
Tidsramme: 6 months
|
6 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- R324A150094
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Autismespektrumforstyrrelse
-
Sohag UniversityTilmelding efter invitationPlacenta Accrete SpectrumEgypten
-
Charite University, Berlin, GermanyRekrutteringSkizofreni Spectrum Disorders (SSD)Tyskland
-
Corestemchemon, Inc.Ikke rekrutterer endnuNeuromyelitis Optica Spectrum Disorder Tilbagefald
-
Kasr El Aini HospitalRekrutteringGraviditet | Apgar score | Tourniquets | Placenta Accrete SpectrumEgypten
-
Assiut UniversityUkendtPlacenta Accrete SpectrumEgypten
-
Novartis PharmaceuticalsAfsluttetPIK3CA-Relateret Overgrowth Spectrum (PROS)Spanien, Frankrig, Australien, Forenede Stater, Irland
-
Jagannadha R AvasaralaAfsluttetMultipel sclerose | Optisk neuritis | Neuromyelitis Optica Spectrum Disorder Attack | Neuromyelitis Optica Spectrum Disorder Tilbagefald | Neuromyelitis Optica Spectrum Disorder ProgressionForenede Stater
-
Kaleido BiosciencesAfsluttetVancomycin-resistente Enterococcus, Extended-Spectrum Beta Lactamase-producerende Enterobacteriaceae eller Carbapenem-resistente Enterobacteriaceae koloniserede forsøgspersonerForenede Stater
-
Hansoh BioMedical R&D CompanyHorizon Therapeutics Ireland DACIkke rekrutterer endnuNeuromyelitis Optica Spectrum DisordersKina
-
RemeGen Co., Ltd.AfsluttetNeuromyelitis Optica Spectrum DisordersKina